Font Size: a A A

Evaluation Of Therapeutic Efficiency And Mechanical Research On Chinese Health Qigong Prevent And Cure Patients Of Stable Of Chronic Obstructive Pulmonary Disease

Posted on:2012-08-17Degree:DoctorType:Dissertation
Country:ChinaCandidate:X D LiuFull Text:PDF
GTID:1114330338960775Subject:Acupuncture and Massage
Abstract/Summary:PDF Full Text Request
Objective:To make the verification of therapeutic efficiency on Chinese Health Qigong Lung Prescription treating patients with stable COPD through a systematic literature review and clinical research,and further explore the mechanism of its role.Method:The subjects was came from Provincial Authorities of Jiangsu Province in October 2008 to October 2010 during the month of outpatient and hospital wards after discharge line with 2007, "Diagnosis and treatment of chronic obstructive pulmonary disease guidelines standards " in the standard diagnostic criteria and classification of gradeâ… andâ…¡118 cases of patients with stable COPD. Which,â… grade were randomly divided into control group 1 in 17 cases,15 cases were 2, the experimental group of 25 patients. Three groups are not taking the drugs, the implementation of the control group 2 reduced lip breathing + walking prescription, the experimental group perform Chinese Health Qigong Lung Prescription prescription. Gradeâ…¡61 patients were randomly divided into control a group of 18 patients,17 patients in control group 2, the experimental group 26 cases. Three groups were taking medication Seretide, control group 2 drugs on the basis of the implementation of reduced lip breathing + walking prescription, the experimental group on the basis of taking the drug, plus practicing Chinese Health Qigong Lung Prescription prescription. The implementation of prescriptions for 6 months, and observed after 6 months of treatment before and after Chinese Health Qigong Lung Prescription pulmonary function, exercise capacity, clinical symptom scores, quality of life score, arterial blood gas analysis, the number of acute onset, efficacy, dosage changes, adverse reactions Changes in other indicators.Result:Grade I:1)There was no difference between three groups before and after experiment on FEV1 (%) and FEV1/FVC (%) no significant difference between the two groups no difference.2)Control group 1 before and after the 6min walking distance of the experiment no difference; the control group and experimental group 2 and experimental before and after the experiment were significantly different, with the control group 1 were significantly different between groups.3)Control group 1 before and after the experiment was no difference in clinical symptom score; the control and experimental group 2 before and after the experiment cough, sputum, wheezing, shortness of breath symptom scores decreased significantly; spontaneous, easy cold, wheeze was no difference in symptom score; and control Group 1 between the two groups breathing, shortness of breath symptom scores decreased significantly; cough symptom score had decreased; sputum, spontaneous, easy cold, wheeze was no difference in symptom scores. Experimental group before and after the experiment and experimental cough, sputum, wheezing, easy to cold, shortness of breath symptom scores decreased significantly; spontaneous, wheeze symptom scores did not change; with the control group 1 between the two groups breathing, easy cold symptom scores decreased significantly; cough, shortness of breath symptom score had decreased; sputum, spontaneous, wheeze was no difference in symptom score; and control group 2 between the two groups easy cold symptom scores decreased significantly.4) Quality of life scores in control group 1 and experimental before and after the experiment was no different. Control group 2 activities of daily living and anxiety symptom scores compared with scores before the experiment significantly decreased; psychological symptoms of depression compared with rates before the experiment to decrease; social activities scores were not significantly before the experiment. With the control group 1 between the two groups have decreased anxiety symptom scores, the other no difference. Quality of life scores in the experimental group, activities of daily living, anxiety symptoms, depressive symptoms and psychological test scores were significantly decreased compared with that before; social activities scores were not significantly before the experiment. After the experiment group and control group 1 between the psychological symptoms of anxiety were significantly different, daily living skills, psychological symptoms of depression are different; with the control group 2 no significant difference between the two groups. Three groups before the experiment was no difference between the two groups.5) Control group 1 after the experiment PaO2, PaCO2 and no difference before the experiment; the control and experimental group 2 before and after the experiment significantly increased PaO2, PaCO2 no difference; with the control group 1 between the two groups increased PaO2, PaCO2 no difference. Experimental group before and after the experiment and the experiment significantly increased PaCCO2 no difference; with the control group 1 between the two groups increased PaCO2, PaCCO2 no difference; with the control group 2 no significant difference between the two groups.6) The control group 1 before and after experiment no difference between the number of acute attacks; control group 2 before and after the experiment was no difference between the number of acute attacks; the experimental group compared before and after experiment with different number of acute attack.7) After three sets of experiments Integrated efficacy was no difference in efficacy of TCM symptoms comparison experiment:the control group 2 and control group 1 were significantly different; the experimental group and control group 1 were significantly different; the experimental group and control group 2 was no different.8) Three groups of tumor necrosis factor, interleukin -8, interleukin -6 indexes in both experiments before and after comparison or contrast there was no difference between the groups.Grade II1) Three groups before and after the experiment and experimental FEV1 (%) and FEV1/FVC (%) were significantly increased, there was no experimental difference between the two groups before and after.2) The control group 1 before and after the experiment 6min walk distance significantly increased; the control and experimental group 2 before and after the experiment 6min walk distance increased significantly with the control group 1 between the two groups had elevated; the experimental group and after the experiment 6min walk distance compared before the experiment significantly increased; and with the control group 1 group increased compared with the control group 2 no significant difference between the two groups. Each group before the experiment was no difference between the two groups.3) The control group 1 before and after the experiment:cough, shortness of breath symptom scores decreased significantly; wheezing, easy integration to decrease cold symptoms. Control and experimental group 2 before and after the experiment: cough, spontaneous symptom scores decreased significantly; wheezing, easy to cold, shortness of breath symptom scores have decreased. Experimental group before and after the experiment and the experiment:coughing, wheezing, easy to cold, shortness of breath symptom scores decreased significantly 4) Quality of life scores in control group 1 and experimental before and after the experiment:activities of daily living score was significantly decreased, the other not statistically significant. Control group 2 quality of life scores before and after the experiment and the experiment:activities of daily living score was significantly decreased, the other not statistically significant. Experimental group, the quality of life scores before and after the experiment and the experiment:daily living, symptom score decreased anxiety, depression and psychological symptom score had decreased; with the control group 1 between the two groups significantly decreased activities of daily living scores, psychological symptom score had decreased depression Other unchanged. Before the experiment was no difference between the two groups.5) Control group 1 before and after the experiment:PaO2 no difference, PaCO2 had decreased. Control and experimental group 2 before and after the experiment: PaO2 has increased, PaCO2 had decreased. Experimental group before and after the experiment and the experiment:PaO2 had increased, PaCO2 decreased significantly. Before and after experiment no difference between the two groups.6) Three groups before and after the experiment and the experimental number of acute attack are different.7) Three integrated effect and after the experiment showed no difference in efficacy of traditional Chinese medicine symptoms.8) Dosage experiment in control group 2 compared with the control group 1 decreased in the experimental group compared with the control group 1 decreased; the experimental group and control group 2 showed no difference.9) Control group 1 before and after the experiment and experimental tumor necrosis factor, interleukin -8, interleukin -6 were decreased in the control and experimental group 2 before and after the experiment:tumor necrosis factor, interleukin -8 decreased significantly, IL-6 were decreased; and control group 1 no significant difference between the two groups. Experimental group before and after the experiment and the experiment:tumor necrosis factor, interleukin -8 have significantly decreased, a decreasing interleukin-6; with the control group 1 between the two groups of tumor necrosis factor has dropped, the other no difference. Each group before the experiment was no difference between the two groups.Conclusion:(1) Chronic obstructive pulmonary diseases are among the Chinese, "cough, asthma card, lung inflation " and other areas, and in early clinical manifestations similar to cough medicine, as the disease progresses, further aggravating lung injury, clinical manifestations and asthma Card similar to the further development when the disease, manifested as severe emphysema or pulmonary heart disease, the clinical manifestations of lung inflation is the scope of traditional Chinese medicine. (2) for chronic obstructive pulmonary disease prevention and control should be based on coupon-based, that benefit of the virtual failure of lung, spleen and kidney to its present solid. (3) Chinese Health Qigong Lung Prescription for chronic obstructive pulmonary disease with good prevention and adjuvant therapy, is a simple, effective and appropriate ways to promote pulmonary rehabilitation; (4) Chinese Health Qigong Lung Prescription By adjusting God, qigong breathing state, is a medium intensity aerobic exercise, lung, spleen, kidney and other dirty regulation, the "three tune " One and other aspects of chronic obstructive pulmonary disease prevention and control play a better role.
Keywords/Search Tags:Chinese Health Qigong Lung Prescription, Chronic obstructive pulmonary disease, Stable, Clinical efficacy, Immune cell factors
PDF Full Text Request
Related items
Clinical Observation Of Treating The Remission Grade Ⅰ Chronic Obstructive Pulmonary Diesease With The Prescription Of Health Qigong Raise Lung
The Evaluation Of The Clinical Efficacy Of Feizhang 2 Prescription And Its Effects Of Oxidative Stress In Patients With Stable Chronic Obstructive Pulmonary Disease With Lung And Kidney Qi-Yin Deficiency Syndrome
The Efficacy Observation Of Regulating And Reinforcing Lung And Kidney In Stable Phase Patients With Chronic Obstructive Pulmonary Disease
Clinical Study On Effect Of Health-qigong Ba Duan Jin In Treating Chronic Obstructive Pulmonary Disease (Stationary Phase)
Clinical Observation Of Pei Tu Sheng Jin Decoction In Treating Chronic Obstructive Pulmonary Disease With Deficiency Of Spleen Qi In Stable Phas
Clinical Efficacy Of Jiu Wei Gu Jin Capsule In The Treatment Of Chronic Obstructive Pulmonary Disease With Deficiency Of Lung And Kidney At Stable Stage
The Research On Curative Effect And Influence Of MMP-9with Lung Qi Deficiency Type Of Chronic Obstructive Pulmonary Disease In Stable Phase By Bufei First Prescription
Tune Up The Treatment Of Chronic Obstructive Pulmonary Disease With Stable Clinical Efficacy Evaluation Index System Of The Lung And Kidney France
Thrift Lung Party For The Treatment Of Chronic Obstructive Pulmonary Disease Stabilization Lung Temper Deficiency Syndrome Clinical Research
10 Observation Of Clinical Efficacy Of Peiyuan Guben Method In The Treatment Of Stable Chronic Obstructive Pulmonary Disease